Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation (Q40150731)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2007
edit
Language Label Description Also known as
English
Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation
scientific article published on January 2007

    Statements

    Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation (English)
    Monia Lenzi
    Davide Sciuscio
    Giorgio Cantelli-Forti
    1 January 2007
    1095
    62-69

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit